| Drug                                                                                | Safety monitoring tests                                         |
| ----------------------------------------------------------------------------------- | --------------------------------------------------------------- |
| Methotrexate                                                                        |                                                                 |
| At 3 weeks, 6 weeks, 12 weeks, then every 3-6 months                                | Basic blood count with platelets + differential count, ALT      |
| Every 6 months                                                                      | Creatinine (in case of impaired renal function, dose reduction) |
| Hydroxychloroquine                                                                  |                                                                 |
| No laboratory monitoring needed. Checkup by an ophthalmologist after 5 years of use |                                                                 |
